Relevant bibliographies by topics / ST elevation acute myocardial infarction (STEMI)

Academic literature on the topic 'ST elevation acute myocardial infarction (STEMI)'

Author: Grafiati
Published: 10 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'ST elevation acute myocardial infarction (STEMI).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "ST elevation acute myocardial infarction (STEMI)"

1

Suthar, Nilay, Chintal Vyas, and Abhishek Raval. "A Study of ST-Elevation Acute Myocardial Infarction (STEMI) in Youngs." Indian Journal of Applied Research 4, no. 3 (October 1, 2011): 393–96. http://dx.doi.org/10.15373/2249555x/mar2014/123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kurniawan, Paulus Rio, Andreas Arie Setiawan, Charles Limantoro, and Ariosta Ariosta. "THE DIFFERENCES IN TROPONIN I AND CK-MB VALUES IN ACUTE MYOCARDIAL INFARCTION PATIENTS WITH ST ELEVATION AND WITHOUT ST ELEVATION." DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO) 10, no. 2 (March 31, 2021): 138–44. http://dx.doi.org/10.14710/dmj.v10i2.29601.

Full text
Abstract:
Background: Acute myocardial infarction includes STEMI and NSTEMI. In STEMI and NSTEMI, an increase in cardiac biomarkers especially troponin I and CK-MB are affected by the ischemic process. In STEMI thrombus blocks the entire artery lumen while in NSTEMI thrombus does not block the entire artery lumen. This can lead to different ischemic processes. Aim: To prove the differences in troponin I and CK-MB values in acute myocardial infarction patients with ST-elevation and without ST- elevation. Methods: An observational analytic study using a cross-sectional design was conducted between April and September 2020. The total sample of the study was 48 samples, consists of 25 samples with STEMI and 23 samples with NSTEMI. The normality test was analyzed using Shapiro-Wilk test. The difference test was analyzed using Mann-Whitney test. Results: Mean troponin I values of STEMI and NSTEMI patients were 30.40 ± 20.79 ng/mL; 1.38 ± 1.76 ng/mL, respectively. Mean CK-MB values in STEMI and NSTEMI patients were 386.12 ± 319.70 U/L; 42.39 ± 27.54 U/L, respectively. There were statistically significant differences in troponin I and CK-MB values (p respectively 0.00; 0.00) in STEMI patients compared to NSTEMI patients. Conclusion: There were differences in troponin I and CK-MB values between STEMI and NSTEMI patients. The troponin I and CK-MB values in STEMI patients were higher than in NSTEMI patients.
APA, Harvard, Vancouver, ISO, and other styles
3

Tucker, Bradley, and Sanjay Patel. "Acute Coronary Syndrome: Unravelling the Biology to Identify New Therapies." Cells 11, no. 24 (December 19, 2022): 4136. http://dx.doi.org/10.3390/cells11244136.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Nambiar, Dr Supriya D. "Cardiac and Extra Cardiac Predictors and Complications of Acute Atrial Fibrillation Complicating ST Elevation Myocardial Infarction (STEMI) ST Elevation myocardial infarction Acute Atrial Fibrillation (STAAF) Study." Journal of Medical Science And clinical Research 05, no. 05 (May 23, 2017): 22124–34. http://dx.doi.org/10.18535/jmscr/v5i5.139.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ikramullah, Syed, Aamna Khokhar, Muhammad Usman Ali, Bilal Mustafa, Syed Ahsan Raza, and Iftikhar Ahmad. "Frequency of Vitamid Deficiency in Patients with Acute ST Elevation MI." Pakistan Journal of Medical and Health Sciences 16, no. 5 (May 29, 2022): 1102–4. http://dx.doi.org/10.53350/pjmhs221651102.

Full text
Abstract:
Objective: Vitamin D deficiency in individuals with acute ST Elevation is the goal of this study. Stud Design: Case control/Prospective study Place and Duration: Conducted at Islamabad medical and dental college, Islamabad. Duration was six months from 1st July, 2021 to 31st Dec, 2021. Methods: There were one hundred and six patients were presented in this study. ACS patients were included if they had ST elevation myocardial infarction (STEMI) or not if they had non-STEMI. Informed permission was obtained prior to obtaining demographic data on the enrolled patients. These demographics included age, sex, BMI, and any co-morbidities they may have. Patients were divided in two groups, group I had 53 patients had ST elevation myocardial infarction (STEMI) and group B had 53 patients without STEMI. Frequency of vitamin deficiency among both groups were assessed and compared. SPSS 24.0 was used to analyze complete data. Results: There were majority males 68 (64.2%) and 38 (35.8%) females among all patients. Mean age of the patients was 56.8±11.53 years with mean BMI 27.12±14.43 kg/m2 in group I and in group II mean age was 54.13±6.23 years and had mean BMI 25.7±10.51 kg/m2. Hypertension, diabetes mellitus, myocardial infarction and dyslipidemia were the commonest comorbidities found among all cases. Frequency of vitamin D deficiency in group I was higher found in 42 (79.2%) cases as compared to group II found in 22 (41.5%) cases with p value <0.004.Frequency of vitamin D insufficiency was also higher in patients with STEMI. Conclusion: Vitamin D deficiency and insufficiency were shown to be more common in individuals with acute coronary syndrome, including ST-elevation myocardial infarction (STEMI). People with ACS who had a vitamin D deficit were more likely to have an ST-elevation myocardial infarction (MI). Keywords:Acute coronary syndrome, ST elevation myocardial infarction (STEMI), Vitamin D Deficiency, Comorbidities
APA, Harvard, Vancouver, ISO, and other styles
6

Kireyev, Dmitriy, Huay Cheem Tan, and Kian Keong Poh. "Management of Acute ST-Elevation Myocardial Infarction: Reperfusion Options." Annals of the Academy of Medicine, Singapore 39, no. 12 (December 15, 2010): 927–33. http://dx.doi.org/10.47102/annals-acadmedsg.v39n12p927.

Full text
Abstract:
Primary percutaneous coronary intervention and thrombolysis remain therapies of choice for patients presenting with ST-segment elevation myocardial infarction (STEMI). Clinical outcome in the management of acute STEMI is dependent on myocardial reperfusion time and reperfusion strategies. Optimisation of these strategies should take into consideration logistical limitations of the local medical systems and the various patient profiles. We review the reperfusion strategies and its history in Singapore, comparing its clinical application with that in some developed Western countries. Key words: Acute Myocardial Infarction, Primary Percutaneous Coronary Intervention, ST segment Elevation Myocardial Infarction, Thrombolysis
APA, Harvard, Vancouver, ISO, and other styles
7

Ahmad, Munir, Muhammad Yasir, and Asif Rahmat. "ACUTE ST ELEVATION MYOCARDIAL INFARCTION." Professional Medical Journal 25, no. 05 (May 10, 2018): 777–83. http://dx.doi.org/10.29309/tpmj/2018.25.05.325.

Full text
Abstract:
Objective: To determine the frequency of in-hospital outcomes in patients ofacute ST elevation myocardial infarction (STEMI) within five days of hospitalization with .70ST segment resolution 90 minutes post thrombolysis. Study Design: Case series. Place andDuration of Study: Department of Cardiology, Faisalabad Institute of Cardiology, Faisalabad,from April, 2016 to October, 2016. Methodology: In 370 patients fulfilling the inclusion andexclusion criteria a baseline 12 lead electrocardiogram was recorded before initiation ofthrombolysis and at 90 minutes thereafter. Conventional contraindications to thrombolysis wereobserved and streptokinase 1.5 mu was administered by intravenous infusion over 60 minutes.Successful thrombolysis was taken as 70% or more ST elevation resolution at 90 minutes frombaseline electrocardiogram measured 80ms from J-point. Patients with successful thrombolysiswere observed for in-hospital clinical outcomes of recurrent angina, congestive cardiac failure,ventricular arrhythmia and death within five days of hospitalization. Results: Out of 370 cases,51.35 %( n=190) were male while 48.65 %( n=180) were female, 25.14 %( n=93) were between30-50 years of age while 74.86 %( n=277) were between 51-65 years of age, the mean agewas 54.98+5.96 years. Frequency of in-hospital outcome was recorded as 10.67 %( n=38) forcongestive cardiac failure, 14.59 %( n=54) for ventricular arrhythmia, 5.40 %( n=20) for mortalitywhile no case had recurrent angina. Conclusion: In-hospital outcome is better in patients of.70% ST resolution at 90 minutes post thrombolysis .This might assist in identification of lowrisk patients who can be discharged early and should not be considered for early invasivestrategy.
APA, Harvard, Vancouver, ISO, and other styles
8

Rashid, Shazia, Javed Anver Qureshi, Rukhshan Khurshid, Ismat Tahira, Sofia Shoukat, and Uzma Faryal. "Interplay Between Adiponectin, Resistin, Lipoprotein (A) and Prognosis in Middle to old age Female Cases with ST / Non ST Elevation Myocardial Infarction." Pakistan Journal of Medical and Health Sciences 16, no. 8 (August 31, 2022): 627–29. http://dx.doi.org/10.53350/pjmhs22168627.

Full text
Abstract:
Acute myocardial infarction (AMI) refers to ST-elevated myocardial infarction and non ST elevation myocardial infarction, is the known presentation of coronary artery disease. Study was planned to explore the interplay of the adipokines, resistin / lipoprotein (a) and prognosis in middle to old age female patients with ST / Non ST Elevation Myocardial Infarction. Material and Methods: A cross-sectional study was conducted on 150 middle to old age female patients with acute myocardial infarction (AMI). Consented patients were divided into 2 groups based on ST and Non ST elevation. Duration of study was six months from December 2015 to May 2016. Levels of adiponectin, lipoprotein (a) and resistin were measured. 50 healthy subjects matched for age and gender also participated in study. Results: Mean age of patients with NSTEMI was 58.89 while with STEMI was 50.59 years. Decreased levels of serum adinopectin, resistin and lipoprotein A was observed in female patients with NSTEMI in comparison with these parameters of STEMI, but significantly high level was seen in context of resistin. Positive correlation of age with serum adiponectin and resistin and a negative correlation of age with serum lipoprotein (a) was in female patients with STEMI and NSTEMI. Conclusion: Study found a direct interaction of adiponectin and resistin with strong prognosis of ST and weak prognosis of Non ST elevation of myocardial infarction; whereas lipoprotein (a) showed a strong indirect interaction with age in women with both STEMI and NSTEMI. Keywords: Adiponectin, lipoprotein (a), resistin, STEMI and NSTEMI.
APA, Harvard, Vancouver, ISO, and other styles
9

Hashmi, Syed Fasih Ahmed, Mashooq Ali Dasti, Nisar Ahmed Shah, Syed Saad Hussain, Munaza Gohar, Zul Farah, and Syed Zulfiquar Ali Shah. "ST ELEVATION MYOCARDIAL INFARCTION." Professional Medical Journal 22, no. 05 (May 10, 2015): 536–40. http://dx.doi.org/10.29309/tpmj/2015.22.05.1262.

Full text
Abstract:
OBJECTIVE: To evaluate the frequency of hyponatremia and its prognosticimportance in ST elevation myocardial infarction. Period: Six months. Design: Case series.Setting: Tertiary care hospital Hyderabad. Methods: All the cases with ST elevation myocardialinfarction admitted in the CCU were recruited and evaluate for serum sodium level at admissionand then at 24, 48 and 72 hours. The data was analyzed in SPSS 16 and the frequency andpercentage was calculated. Results: One hundred patients with acute myocardial infarctionwere recruited and assessed for sodium level. The mean age ±SD of whole population was57.52±9.51 whereas in male and female population it was 58.72±7.53 and 53.84±7.93respectively. The sodium level was 130.21±3.42 and 127.41±4.21 in male and femalepopulation. The p-value was statistically significant (<0.01) in context to age and sex whereasthe age in context to hyponatremia is non significant (p=0.77). The hyponatremia and itsseverity was statistically significant in context to sex (p=0.04) and duration of the myocardialinfarction (p=0.03). The serum sodium level in context to duration of MI was also significant(p=0.03) whereas the mortality at the end of 30 days was 11% of which 02 patients had normalsodium level while the 09 had low sodium level (hyponatremia). Conclusion: Hyponatremia inpatients with acute STEMI is a important predictor of thirty days mortality.
APA, Harvard, Vancouver, ISO, and other styles
10

Koeth, Oliver, Uwe Zeymer, Rudolf Schiele, and Ralf Zahn. "Inferior ST-Elevation Myocardial Infarction Associated with Takotsubo Cardiomyopathy." Case Reports in Medicine 2010 (2010): 1–4. http://dx.doi.org/10.1155/2010/467867.

Full text
Abstract:
Takotsubo cardiomyopathy (TCM) is usually characterized by transient left ventricular apical ballooning. Due to the clinical symptoms which include chest pain, electrocardiographic changes, and elevated myocardial markers, Takotsubo cardiomyopathy is frequently mimicking ST-elevation myocardial infarction in the absence of a significant coronary artery disease. Otherwise an acute occlusion of the left anterior descending coronary artery can produce a typical Takotsubo contraction pattern. ST-elevation myocardial infarction (STEMI) is frequently associated with emotional stress, but to date no cases of STEMI triggering TCM have been reported. We describe a case of a female patient with inferior ST-elevation myocardial infarction complicated by TCM.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "ST elevation acute myocardial infarction (STEMI)"

1

Al-Mashat, Mariam. "Diagnosis of acute coronary occlusion using computed electrocardiographic imaging based on the 12-lead electrocardiogram, in comparison with ST- elevation myocardial infarction criteria." Thesis, Örebro universitet, Institutionen för hälsovetenskap och medicin, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-23526.

Full text
Abstract:
Introduction: Computed electrocardiographic imaging (CEI) is a method that uses ST- segment deviations from the 12-lead electrocardiogram (ECG) and has been tested on a small number of patients.Aim: To extend the testing material of the CEI method and deduce a threshold using ECGs recorded pre- and during acute occlusion. The performance of the CEI and ST elevation myocardial infarction (STEMI) criteria will be compared. Method: Two CEI images were generated from each of 99 patients before and during complete occlusion in the left anterior descending (LAD), right coronary artery (RCA) and left circumflex coronary artery (LCx). Result: The sensitivity and specificity of STEMI criteria was 61% and 96% respectively for the whole occlusion group. The sensitivities and specificities were 74 %, 97% (LAD); 60%, 94% (RCA); 35%, 100% (LCx) respectively, for STEMI criteria. A threshold of 998 units was deduced from the CEI method. Conclusion: The CEI method has similar diagnostic performance of an occlusion as STEMI criteria.
APA, Harvard, Vancouver, ISO, and other styles
2

Stolic, S., M. Mitchell, and F. Lin. "A Randomised Controlled Trial of a Symptom Management Education Package (SMEP) for People with Acute Coronary Syndrome (ACS)." Thesis, Griffith University, 2017. http://hdl.handle.net/10072/367170.

Full text
Abstract:
More people die of cardiovascular disease in Australia than from any other condition. Acute Coronary Syndrome (ACS) is the acute event of the chronic condition coronary heart disease (CHD) represents a continuing spectrum of three conditions and can be divided into unstable angina, non ST elevation myocardial infarction (NSTEMI) and ST elevation myocardial infarction (STEMI). Patients’ symptoms in all three conditions are self managed by the first line medication sublingual glycerine trinitrate (SLGTN). The aim of management of ACS is to minimise symptoms and improve quality of life (QOL). Education of this complex medication such as recommended route, timing, side effects, prophylactic use and response to emergency when symptoms are not relieved are essential for the person to be able to effectively self administer the medication. Nitrates such as SLGTN have different biovariabilities and pharmokinetic properties which can have potent adverse effects such as vasodilatation if not taken correctly. Patients self-manage and prevent angina symptoms using SLGTN and rest when they are home; therefore it is essential that they have adequate knowledge of SLGTN and its use. However previous studies have reported patients have poor knowledge of SLGTN and appropriate symptom management.
Thesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Nursing and Midwifery
Griffith Health
Full Text
APA, Harvard, Vancouver, ISO, and other styles
3

Callachan, Edward. "Mode of transport to hospital among patients with ST Elevation Acute Myocardial Infarction (STEMI) in the Emirate of Abu Dhabi: correlates, physician and patient attitudes, and associated clinical outcomes." Doctoral thesis, University of Cape Town, 2017. http://hdl.handle.net/11427/25168.

Full text
Abstract:
Introduction: Acute coronary syndromes, including ST-elevation myocardial infarction (STEMI), are a leading cause of morbidity and mortality worldwide. Existing research shows that prehospital care provided by emergency medical services (EMS) can significantly improve outcomes. However, EMS remains grossly underutilised in Abu Dhabi despite a well-established presence. Objectives: In this three-part quantitative, observational study, we sought to (1) assess physicians' perceptions of, and recommendations for, utilization and improvement of EMS, (2) assess patients' awareness of EMS, mode of transport use in decision to seek care and reasons for their decision, and (3) establish if in the current study setting, mode of transport used has implications for in hospital adverse events, as well as short and long term clinical outcomes. The goal was to investigate both physicians' and patients' perceptions of prehospital STEMI care, as well as to assess the clinical correlates of the mode of transport in a patient's decision to seek care. Methods: We conducted the study in three phases. Phase 1: At four government-operated hospitals in Abu Dhabi, we administered surveys to a convenience sample of physicians involved in care of patients with acute coronary syndromes to measure (a) likelihood of recommending EMS, (b) satisfaction with EMS, (c) likelihood of using EMS for self or family, and (d) recommendations for prehospital care of acute coronary syndromes. Phase 2: We gathered mode of transport data from a purposive, non-random sample of 587 consecutive patients with STEMI over an 18-month period and conducted structured follow-up interviews to assess their perceptions of EMS. We conducted analysis to determine whether mode of transport was related to demographic variables. Phase 3: We collected medical records from patient participants and conducted structured follow-up interviews at 1, 6 and 12 months post discharge. We conducted chi square difference testing to determine the relationships among mode of transport, treatment times, and short- and long-term clinical outcomes. Variables included treatment times and associated outcomes. Results: Physician participants (n = 106) were most supportive of prehospital 12-lead ECG for STEMI, but indicated low satisfaction with existing EMS services in Abu Dhabi. Among STEMI patient participants (n = 587), EMS was underutilized in Abu Dhabi; over half (55%) of patients did not know the phone number to contact EMS, and only 14.7% used EMS in their decision to seek care. EMS-transported patients were more likely to receive timely treatment (door-todiagnostic ECG time, door-to-balloon time) and had lower incidence of mortality compared to privately-transported patients. Conclusions: These findings suggest a need to raise public awareness of EMS and its importance for coronary symptoms in Abu Dhabi. Broader application of prehospital ECG, including prehospital activation of cardiac catheterization labs, bypassing non-interventional cardiology centres, and admission directly to facilities that provide these services without initial admission to the emergency department, could help improve physicians' perceptions of EMS and outcomes for patients with STEMI.
APA, Harvard, Vancouver, ISO, and other styles
4

Watanabe, Hiroki. "Chronic total occlusion in non-infarct-related artery is closely associated with increased five-year mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (From the CREDO-Kyoto AMI registry)." 京都大学 (Kyoto University), 2017. http://hdl.handle.net/2433/225504.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

McAlindon, Elisa. "Cardiovascular magnetic resonance in ST-segment elevation myocardial infarction (CMR in STEMI)." Thesis, University of Bristol, 2015. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.681480.

Full text
Abstract:
Myocardial infarction is a leading cause of morbidity and mortality in the developed world. Cardiovascular magnetic resonance (CMR) is an imaging technique that provides non-invasive tissue characterisation of the myocardium. CMR can, therefore, quantify myocardial infarct characteristics in vivo. This aim of this work is to investigate the CMR parameters used to assess and quantify injury following myocardial infarction. The research questions in this thesis are: • How reliable are the CMR parameters found in myocardial infarction? • Can newer sequences impact on the reliability of the assessment of myocardial oedema? • Are existing sequences available for infarct size measurement interchangable? • How does a functional measure of microvascular dysfunction relate to microvascular obstruction identified on CMR? • What can new T1 and T2 mapping sequences contribute to the assessment of myocardial infarction by CMR? CMR is increasingly being used to quantify surrogate endpoints used in myocardial infarction studies. In Chapter 4, pilot work identified that the reproducibility of these end points can vary depending on the expertise of the observer. Chapter 5 determined the most reliable method available for quantifying myocardial · oedema and myocardial infarction was manual contouring. This technique was then used in Chapter 7 to establish the repeatability of CMR parameters used as surrogate endpoints in clinical trials. Chapter 7 identified that the least reproducible CMR parameter measured in acute myocardial infarction was myocardial oedema. Chapter 8 sought to address this issue by evaluating 4 sequences to identify and quantitate myocardial oedema. Of these, a new T2 mapping sequence was the most reproducible for quantitating myocardial oedema. New mapping sequences, both Tl and T2 mapping were further evaluated in Chapter 11 to investigate a cut off value for T2 value in oedematous myocardium following acute myocardial infarction. Chapter 11 also established that infarct characteristics affect the T2 value in affected myocardium. The association between native Tl and T2 mapping and between the extracellular volume and myocardial oedema was also determined. Chapter 7 also highlighted that quantification of myocardial infarction could be improved. Single shot steady state free precession (SS -SSFP) late gadolinium enhancement imaging was assessed against the standard inversion recovery gradient echo sequences in Chapter 9. Although the identification of myocardial infarction was acceptable with the SS-SSFP, quantification was suboptimal with this sequence and therefore should not be used for quantification of infarct size. Despite restoration of flow to the epicardial infarct related artery following acute myocardial infarction, flow is not necessarily optimal in the microvasculature. Chapter 10 provides an in vivo functional insight into microvascular obstruction (MVO) identified on CMR following ST segment elevation myocardial infarction (STEM!) using an invasive measure (the index of microcirculatory resistanceIMR) at the time of primary angioplasty. There is a good association between the IMR and MVO on CMR
APA, Harvard, Vancouver, ISO, and other styles
6

Huynh, Thao Thanh 1963. "Time to reperfusion therapy in acute ST-elevation myocardial infarction in Quebec." Thesis, McGill University, 2006. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=98731.

Full text
Abstract:
The objectives of this thesis are to describe door-to-reperfusion therapy wait times in ST-elevation myocardial infarction (STEMI) at selected hospitals in Quebec, and to identify factors associated with prolonged wait times. We undertook an observational study of patients with STEMI who received reperfusion therapy, at 17 hospitals in Quebec in 2003. Door-to-reperfusion therapy wait times were available for 1,189 of 1,432 patients for patients who received reperfusion therapy. The median door-to-reperfusion therapy wait times were 32 minutes for patients who received fibrinolytic therapy, and 145 and 109 minutes for patients who underwent primary percutaneous coronary intervention (PCI) with and without inter-hospital transfers, respectively.
We conclude that door-to-reperfusion therapy wait times for STEMI approached recommended times for fibrinolytic therapy, but remained prolonged for primary PCI at these 17 hospitals in 2003. Efforts are needed to reduce door-to-reperfusion therapy wait times and especially wait times to primary PCI, to assure maximum benefits from prompt delivery of reperfusion therapy for patients with STEMI.
APA, Harvard, Vancouver, ISO, and other styles
7

Björklund, Erik. "Early Risk Stratification, Treatment and Outcome in ST-elevation Myocardial Infarction." Doctoral thesis, Uppsala University, Department of Medical Sciences, 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-6050.

Full text
Abstract:

We evaluated, in patients with ST-elevation myocardial infarction (STEMI) treated with thrombolytics, admission Troponin T (tnT), ST-segment resolution and admission N-terminal pro-brain natriuretic peptide (NT-proBNP) for early risk stratification as well as time delays and outcome in real life patients according to prehospital or in-hospital thrombolytic treatment. Also, baseline characteristics, treatments and outcome in patients enrolled in the ASSENT-2 trial in Sweden and in patients not enrolled were evaluated.

TnT (n=881) and NT-proBNP (n=782) on admission and ST-resolution at 60 minutes (n=516) in patients from the ASSENT-2 and ASSENT-PLUS trials were analysed. Elevated levels of NT-proBNP and tnT on admission were both independently related to one-year mortality. However, when adding information on ST-resolution (

We investigated consecutive STEMI patients included in the RIKS-HIA registry between 2001 and 2004, if they were ambulance transported and had received prehospital (n=1690) or in-hospital (n=3685) thrombolytic treatment. Prehospital diagnosis and thrombolysis reduced the time to thrombolysis by almost one hour, were associated with better left ventricular function and fewer complications and reduced the adjusted one-year mortality by 30% compared with in-hospital thrombolysis.

Prospective data from the RIKS-HIA registry on STEMI patients treated with thrombolytics were linked to data on trial participants in the ASSENT-2 trial of thrombolytic agents and used for direct comparisons. Patients treated with thrombolytics and not enrolled in a clinical trial at trial hospitals (n=2048) had higher risk characteristics, more early complications and twice as high adjusted one-year mortality compared to those enrolled (n=729). One major reason for the difference in outcome appeared to be the selection of less critically ill patients to the trial.

APA, Harvard, Vancouver, ISO, and other styles
8

Aasa, Mikael. "Reperfusion therapy in acute ST-elevation myocardial infarction a comparison between primary percutaneous intervention and thrombolysis in a short- and long-term perspective /." Stockholm : Department of Clinical Science and Education, Karolinska Institutet, 2010. http://diss.kib.ki.se/2010/978-91-7409-703-0/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cannistraci, Carlo Vittorio, Tuomo Nieminen, Masahiro Nishi, Levon M. Khachigian, Juho Viikilä, Mika Laine, Domenico Cianflone, et al. ""Summer Shift": A Potential Effect of Sunshine on the Time Onset of ST‐Elevation Acute Myocardial Infarction." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2018. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-235086.

Full text
Abstract:
Background: ST-elevation acute myocardial infarction (STEMI) represents one of the leading causes of death. The time of STEMI onset has a circadian rhythm with a peak during diurnal hours, and the occurrence of STEMI follows a seasonal pattern with a salient peak of cases in the winter months and a marked reduction of cases in the summer months. Scholars investigated the reason behind the winter peak, suggesting that environmental and climatic factors concur in STEMI pathogenesis, but no studies have investigated whether the circadian rhythm is modified with the seasonal pattern, in particular during the summer reduction in STEMI occurrence. Methods and Results: Here, we provide a multiethnic and multination epidemiological study (from both hemispheres at different latitudes, n=2270 cases) that investigates whether the circadian variation of STEMI onset is altered in the summer season. The main finding is that the difference between numbers of diurnal (6:00 to 18:00) and nocturnal (18:00 to 6:00) STEMI is markedly decreased in the summer season, and this is a prodrome of a complex mechanism according to which the circadian rhythm of STEMI time onset seems season dependent. Conclusions: The “summer shift” of STEMI to the nocturnal interval is consistent across different populations, and the sunshine duration (a measure related to cloudiness and solar irradiance) underpins this season-dependent circadian perturbation. Vitamin D, which in our results seems correlated with this summer shift, is also primarily regulated by the sunshine duration, and future studies should investigate their joint role in the mechanisms of STEMI etiogenesis.
APA, Harvard, Vancouver, ISO, and other styles
10

Collinson, Julian Rupert. "Clinical outcomes, risk stratification practice patterns and health economics of acute coronary syndromes without ST elevation : prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK)." Thesis, Imperial College London, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.391596.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "ST elevation acute myocardial infarction (STEMI)"

1

Erlinge, David, and Göran Olivecrona. Diagnosis and management of ST-elevation of myocardial infarction. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0147.

Full text
Abstract:
ST-elevation myocardial infarction (STEMI) is generally caused by a ruptured plaque that triggers local thrombus formation, which occludes the coronary artery. STEMI should be diagnosed rapidly, based on the combination of ST-segment elevation and symptoms of acute myocardial infarction. The main treatment objective is myocardial tissue reperfusion as quickly as possible. The preferred method of reperfusion is primary percutaneous coronary interventionif transport time is below 2 hours, and thrombolysis if longer STEMI patients with acute onset cardiogenic shock should be evaluated by echocardiography to exclude mechanical complications, such as flail mitral insufficiency, ventricular septal defect or tamponade. Secondary prevention includes aspirin, adenosine diphosphate receptor antagonists, statins, beta-blockers, angiotensin-converting enzymeinhibitors, and lifestyle changes.
APA, Harvard, Vancouver, ISO, and other styles
2

Shirodaria, Cheerag, and Sam Dawkins. Acute coronary syndromes. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0090.

Full text
Abstract:
The term ‘acute coronary syndrome’ includes unstable angina, ST-elevation myocardial infarction (STEMI), and non-ST-elevation myocardial infarction (NSTEMI). The difference between these three syndromes is as follows. In STEMI and NSTEMI, there is evidence of myocardial necrosis, as evidenced by raised cardiac enzymes, specifically, the very sensitive cardiac biomarker troponin. STEMI is diagnosed when the ECG shows persisting ST elevation in an appropriate territory consistent with STEMI whereas, in NSTEMI, there can be any or no ECG changes, or very transient, self-limiting ST elevation. In unstable angina, there is no myocardial necrosis, and troponins are normal. The ECG is as for NSTEMI and often shows no change, ST depression, or T-wave inversion. The prognoses in STEMI and NSTEMI are identical; unstable angina has a better prognosis than either STEMI or NSTEMI.
APA, Harvard, Vancouver, ISO, and other styles
3

Huber, Kurt, and Tom Quinn. Systems of care for patients with acute ST elevation myocardial infarction (STEMI networks). Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0042.

Full text
Abstract:
Although primary percutaneous coronary intervention is the preferred strategy for patients with ST elevation myocardial infarction, offering a fast access to this procedure often remains difficult, because of local resources and capabilities and a lack of cooperation and organization. Accordingly, for most countries worldwide, primary percutaneous coronary intervention can be provided for only part of the population. Moreover, not all patients referred for primary percutaneous coronary intervention receive an optimal mechanical reperfusion within the recommended time intervals with the procedure performed in an experienced centre by an experienced team. Intravenous thrombolytic therapy, preferably administered pre-hospital and as part of a pharmacoinvasive strategy, offers a reasonable therapeutic option in selected cases. Network organization is central to offering fast and optimal reperfusion treatment in the individual case. It has been shown repeatedly that an early recognition of ST elevation myocardial infarction, as well as minimizing time delays, is important for the achievement of optimal clinical results. These findings should encourage the building up of regional networks, according to specific local constraints, and the monitoring of their effectiveness by ongoing registries. Financial, regulatory, and political barriers can be resolved, and a prompt guideline-recommended care becomes feasible and affordable if stakeholders and participants agree and cooperate.
APA, Harvard, Vancouver, ISO, and other styles
4

Huber, Kurt, and Tom Quinn. Systems of care for patients with acute ST elevation myocardial infarction (STEMI networks). Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199687039.003.0042_update_001.

Full text
Abstract:
Although primary percutaneous coronary intervention is the preferred strategy for patients with ST elevation myocardial infarction, offering a fast access to this procedure often remains difficult, because of local resources and capabilities and a lack of cooperation and organization. Accordingly, for most countries worldwide, primary percutaneous coronary intervention can be provided for only part of the population. Moreover, not all patients referred for primary percutaneous coronary intervention receive an optimal mechanical reperfusion within the recommended time intervals with the procedure performed in an experienced centre by an experienced team. Intravenous thrombolytic therapy, preferably administered pre-hospital and as part of a pharmacoinvasive strategy, offers a reasonable therapeutic option in selected cases. Network organization is central to offering fast and optimal reperfusion treatment in the individual case. It has been shown repeatedly that an early recognition of ST elevation myocardial infarction, as well as minimizing time delays, is important for the achievement of optimal clinical results. These findings should encourage the building up of regional networks, according to specific local constraints, and the monitoring of their effectiveness by ongoing registries. Financial, regulatory, and political barriers can be resolved, and a prompt guideline-recommended care becomes feasible and affordable if stakeholders and participants agree and cooperate.
APA, Harvard, Vancouver, ISO, and other styles
5

Huber, Kurt, and Tom Quinn. Systems of care for patients with acute ST elevation myocardial infarction (STEMI networks). Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199687039.003.0042_update_002.

Full text
Abstract:
Although primary percutaneous coronary intervention is the preferred strategy for patients with ST elevation myocardial infarction, offering a fast access to this procedure often remains difficult, because of local resources and capabilities and a lack of cooperation and organization. Accordingly, for most countries worldwide, primary percutaneous coronary intervention can be provided for only part of the population. Moreover, not all patients referred for primary percutaneous coronary intervention receive an optimal mechanical reperfusion within the recommended time intervals with the procedure performed in an experienced centre by an experienced team. Intravenous thrombolytic therapy, preferably administered pre-hospital and as part of a pharmacoinvasive strategy, offers a reasonable therapeutic option in selected cases. Network organization is central to offering fast and optimal reperfusion treatment in the individual case. It has been shown repeatedly that an early recognition of ST elevation myocardial infarction, as well as minimizing time delays, is important for the achievement of optimal clinical results. These findings should encourage the building up of regional networks, according to specific local constraints, and the monitoring of their effectiveness by ongoing registries. Financial, regulatory, and political barriers can be resolved, and a prompt guideline-recommended care becomes feasible and affordable if stakeholders and participants agree and cooperate.
APA, Harvard, Vancouver, ISO, and other styles
6

D’Auria, Stephen, and Ravi Ramani. Chest Pain and Acute Coronary Syndrome (DRAFT). Edited by Raghavan Murugan and Joseph M. Darby. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190612474.003.0011.

Full text
Abstract:
Chest pain is a common presenting complaint faced by the rapid response team (RRT), and can herald a serious process such as acute coronary syndrome or aortic dissection, or be secondary to a minor muscle strain. A methodical approach to chest pain is necessary to avoid premature diagnostic closure. One of the most feared diagnoses is a myocardial infarction. Fortunately, there are well-established guidelines describing the necessary steps for treatment of both ST elevation myocardial infarction (STEMI) and non-ST elevation myocardial infarction (NSTEMI). This chapter will address the differential for chest pain as well as established guidelines for treatment of acute coronary syndrome.
APA, Harvard, Vancouver, ISO, and other styles
7

Erlinge, David, and Göran Olivecrona. Diagnosis and management of non-STEMI coronary syndromes. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0146.

Full text
Abstract:
Acute coronary syndromes are classified as ST segment elevation myocardial infarction (STEMI), non-STEMI (NSTEMI) or unstable angina. Most patients with NSTEMI present with a history of chest pain that has subsided spontaneously before or soon after arrival at the emergency room, but with positive cardiac markers (usually troponin T or I) indicative of myocardial infarction. NSTEMI has a risk of recurrent myocardial infarction of 15–20% and a 15% chance of 1-year mortality. Patients with non-STE-acute coronary syndromes are at similar risk as a STEMI patient at 1 year. The strongest objective signs of NSTEMI are a positive troponin and ST segment depression. NSTEMI should be acutely treated with aspirin, an adenosine diphosphate-receptor antagonist, and an anticoagulant (fondaparinux or low molecular weight heparins). NSTEMI should be investigated with coronary angiography within 72 hours. Curative treatment is percutaneous coronary intervention or coronary artery bypass grafting.
APA, Harvard, Vancouver, ISO, and other styles
8

Dawson, Dana, and Keith Fox. Anti-Platelet and Anti-Thrombotic Therapy Post-AMI. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199544769.003.0004.

Full text
Abstract:
• Acute coronary syndromes (ACS) encompass a spectrum of presentations which include unstable angina, non-ST-elevation myocardial infarction (NSTEMI or NSTE-ACS), and ST-elevation myocardial infarction (STEMI or STE-ACS)• Anti-platelet and anti-thrombotic agents are administered as ancillary therapy to myocardial reperfusion in patients presenting with an acute coronary syndrome, to maintain the patency of the infarct-related coronary artery• More specific and potent inhibitors of platelet activation and of the coagulation cascade are emerging with the aim being to further improve clinical outcomes in patients presenting with an acute coronary syndrome, without increasing the risks of major bleeding.
APA, Harvard, Vancouver, ISO, and other styles
9

AlJaroudi, Wael. Risk Assessment in Acute Coronary Syndromes. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199392094.003.0013.

Full text
Abstract:
Acute coronary syndromes (ACS) include unstable angina pectoris (UAP), non-ST elevation (NSTEMI), and ST elevation acute myocardial infarction (STEMI). Each year, more than 2 million people are hospitalized with ACS in the United States. The initial treatment has evolved over the last few decades from conservative management to early reperfusion therapy. Medical therapy has also significantly changed with the use of newer more potent antiplatelet agents, beta-blockers, angiotensin converting enzyme inhibitors, statins, and anti-anginal drugs, which have resulted in improvement of patient care and survival. There is no role for stress myocardial perfusion imaging (MPI) in the acute presentation; however, rest MPI may be used to identify the culprit lesion and risk stratify patients if injected during chest pain. In stable patients for ACS, submaximal exercise or vasodilator MPI can be performed as early as 48 hours after the event. Several gated MPI-derived variables such as left ventricular (LV) ejection fraction (EF), LV volumes, infarct size, mechanical dyssynchrony, and residual ischemic burden can risk stratify patients and provide prognostic data incremental to validated clinical risk scores such as GRACE (Global Registry of Acute Coronary Syndrome) and TIMI (Thrombolysis in Myocardial Infarction). Patients with depressed LVEF, remodeled LV, and large perfusion defects are at particularly high- risk for subsequent cardiac death or recurrent myocardial infarction. In such setting, MPI plays a pivotal role in the management of patients and guiding therapeutic decisions. The current chapter will review the clinical and MPI predictors of outcomes in patients presenting with ACS according to updated guidelines and a proposed algorithm integrating the role of MPI in guiding therapeutic decisions and management.
APA, Harvard, Vancouver, ISO, and other styles
10

Kisiel, Maria, and Alison Smith. Cardiac surgery. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642663.003.0026.

Full text
Abstract:
Coronary heart disease is caused by the build-up of atherosclerotic plaques which, over time, narrow the lumen of the coronary arteries. Acute coronary syndrome describes a spectrum of conditions caused by coronary artery disease; these are unstable angina, ST-elevation myocardial infarction (STEMI), and non-ST-elevation myocardial infarction (NSTEMI). Coronary artery disease is the leading cause for cardiac surgical interventions, but other causes are hypertension, valve disease, arrhythmias, cardiomyopathies, infections, and congenital abnormalities. This chapter provides an overview of the signs and symptoms of these conditions, as well as the diagnosis and treatment options available.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "ST elevation acute myocardial infarction (STEMI)"

1

Lee, Justin, Felix Reyes, and Adam S. Budzikowski. "Acute ST-Segment Elevation Myocardial Infarction (STEMI)." In Cardiology Consult Manual, 107–19. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-89725-7_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Stefanini, Giulio G., Margherita Soldi, and Bindu Kalesan. "Interventional Treatment of Acute Coronary Syndrome: ST-Segment Elevation Myocardial Infarction (STEMI)." In Percutaneous Treatment of Cardiovascular Diseases in Women, 61–71. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39611-8_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kashani, John, Richard D. Shih, Thomas H. Cogbill, David H. Jang, Lewis S. Nelson, Mitchell M. Levy, Margaret M. Parker, et al. "ST Elevation Myocardial Infarction (STEMI)." In Encyclopedia of Intensive Care Medicine, 2131. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_2223.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Reed, Michael C., and Brahmajee K. Nallamothu. "Acute ST Elevation Myocardial Infarction." In Inpatient Cardiovascular Medicine, 101–18. Oxford: John Wiley & Sons Inc, 2013. http://dx.doi.org/10.1002/9781118484784.ch8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shreenivas, Satya, and Scott Lilly. "Acute ST Elevation Myocardial Infarction." In Practical Cardiology, 111–23. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-28328-5_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gelfand, Eli V., and Christopher P. Cannon. "ST-Segment-Elevation Myocardial Infarction." In Management of Acute Coronary Syndromes, 79–121. Chichester, UK: John Wiley & Sons, Ltd, 2009. http://dx.doi.org/10.1002/9780470745465.ch4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nguyen, James, Marko Noc, Thach N. Nguyen, Lefeng Wang, Hung M. Ngo, Tan Huay Cheem, and Michael Gibson. "Acute ST-Segment Elevation Myocardial Infarction." In Practical Handbook of Advanced Interventional Cardiology, 269–92. Oxford, UK: Blackwell Publishing Ltd., 2013. http://dx.doi.org/10.1002/9781118592380.ch12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Armstrong, Paul W., and James T. Willerson. "Treatment of Acute ST-Elevation Myocardial Infarction." In Coronary Artery Disease, 505–32. London: Springer London, 2015. http://dx.doi.org/10.1007/978-1-4471-2828-1_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Armstrong, Paul W., and James T. Willerson. "Treatment of Acute ST-Elevation Myocardial Infarction." In Cardiovascular Medicine, 963–77. London: Springer London, 2007. http://dx.doi.org/10.1007/978-1-84628-715-2_43.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gelfand, Eli V., and Christopher P. Cannon. "Unstable Angina and Non-ST-Elevation Myocardial Infarction." In Management of Acute Coronary Syndromes, 37–78. Chichester, UK: John Wiley & Sons, Ltd, 2009. http://dx.doi.org/10.1002/9780470745465.ch3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "ST elevation acute myocardial infarction (STEMI)"

1

Tavakoli, H., and S. Barbant. "Acute Pulmonary Emboli Mimicking Anteroseptal ST-Elevation Myocardial Infarction." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1930.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Oleszewski, Ryan T., and Joshua M. Sill. "ST Elevation That Is Not an Acute Myocardial Infarction: A Case of Pancreatitis-Induced Acute ST Elevation." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6078.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gontina S, Willia, and Atik Nurwahyuni. "Determinants of Inpatient Cost for Patients with ST-Elevation Myocardial Infarct at Mayapada Hospital, Tangerang." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.04.27.

Full text
Abstract:
ABSTRACT Background: Inpatient health services for heart attack patients is a complex problem and the highest billing rate in hospitals. Due to the high cost of hospitalization, delay treatment cases may cause fatal health consequences. This study aimed to determine factors affecting the inpatient cost for patients with ST-elevation myocardial infarction at Mayapada hos­pital, Tangerang, West Java. Subjects and Method: A cross-sectional study was conducted at Mayapada hospital, Tangerang, West Java, from July to December 2019. A sample of 31 patients diagnosed with ST-elevation myocardial infarction (STEMI) was selected by total sampling. The dependent variable was total inpatient service costs counted according to the clinical pathway. The independent variables were doctor in charge presented the direct cost, age, gender, patient’s distance to hospital, payment method, and length of stay. The data were collected using medical records. The data were analyzed by multiple linear regression. Results: Inpatient service cost in STEMI patients was positively associated with the doctor direct cost (b= 0.51; p= 0.003), distance to hospital (b= 0.13; p= 0.501), and length of stay (b= 0.39; p= 0.330). Inpatient service cost in STEMI patients was negatively associated with age (b= -0.30; p= 0.107), gender (b= -0.13; p= 0.550), and payment method (b= -0.26; p= 0.214). Conclusion: Inpatient service cost in STEMI patients have a positive association with the doctor direct cost, distance to hospital, length of stay, and negative association with age, gender, and payment method. Keywords: inpatient service cost, length of stay, STEMI patients Correspondence: Willia Gontina S. Masters Program in Health Policy and Administration, Faculty of Public Health, Universitas Indonesia, Depok, West Java. Email: amyamandacp@gmail.com. Mo­bile: +6281280778000. DOI: https://doi.org/10.26911/the7thicph.04.27
APA, Harvard, Vancouver, ISO, and other styles
4

Joseph, T., B. Kim, C. Fox, L. Kaur, A. Kaur, R. K. N. Santoshi, J. Singh, and V. Bahl. "Acute Severe EBV Myo-Pericarditis Presentation as ST Segment Elevation Myocardial Infarction." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3528.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kohring, A. S., J. R. Bank, C. Burke, and H. Azar. "Acute ST-Segment Elevation Myocardial Infarction in a Young Postinfectious COVID-19 Patient." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1676.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Klester, Elena, Karolina Klester, Yakov Shoikhet, Irina Sheremetyeva, and Alexandra Balitskya. "Assessment of quality of life (QoL) of patients with COPD and with ST-Segment Elevation Myocardial Infarction (STEMI)." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa2661.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

McGinley, C., I. Mordi, P. Kelly, P. Currie, S. Hutcheon, S. Koch, T. Martin, and J. Irving. "11 Effect of pre-hospital administration of unfractionated heparin in acute st-elevation myocardial infarction." In British Cardiovascular Intervention Society, Young Investigator Award Shortlisted Presentations, Royal College of Physicians of London, November 30 2017. BMJ Publishing Group Ltd and British Cardiovascular Society, 2018. http://dx.doi.org/10.1136/heartjnl-2018-bcis.11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wardak, Fazlullah, Simon Cais, and Alex Hobson. "14 Trends in call-to-door times for patients with acute ST-elevation myocardial infarction." In British Cardiovascular Society Annual Conference ‘High Performing Teams’, 4–6 June 2018, Manchester, UK. BMJ Publishing Group Ltd and British Cardiovascular Society, 2018. http://dx.doi.org/10.1136/heartjnl-2018-bcs.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Klester, Karolina, Elena Klester, Alexandra Balitskaya, Irina Sheremetyeva, Valeriy Elykomov, and Mohammed Alaa Abdulamir Alwash. "Current trends in the course, treatment, and outcomes of ST-segment elevation myocardial infarction (STEMI) in patients with COPD." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.2446.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Khan, Nazish, Vincent Amoah, Mike Cornes, Joe Martins, Ben Wrigley, Saib Khogali, Alan Nevill, and James Cotton. "10 Marked differences in the pharmacokinetic and pharmacodynamic profiles of ticagrelor in patients undergoing treatment for ST elevation and non ST elevation myocardial infarction (stemi and nstemi)." In British Cardiovascular Society Annual Conference ‘High Performing Teams’, 4–6 June 2018, Manchester, UK. BMJ Publishing Group Ltd and British Cardiovascular Society, 2018. http://dx.doi.org/10.1136/heartjnl-2018-bcs.10.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "ST elevation acute myocardial infarction (STEMI)"

1

Krastev, Plamen. Dynamics of Left Ventricular Ejection Fraction under Revascularization of Patients with Acute Myocardial Infarction with ST-T Elevation and Single Coronary Artery Disease. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, 2021. http://dx.doi.org/10.7546/crabs.2021.05.16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'ST elevation acute myocardial infarction (STEMI)' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography